Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
AURO-VALACYCLOVIR AURO PHARMA INC Anticipated shortage 500MG Updated Report 2024-05-17 227536
SANDOZ SENNA S SANDOZ CANADA INCORPORATED Actual shortage 50MG 8.6MG Updated Report 2024-05-17 227201
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Actual shortage 40MG Updated Report 2024-05-17 224648
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED Actual shortage 10000UNIT Updated Report 2024-05-17 227194
ATIVAN PFIZER CANADA ULC Anticipated shortage 1MG Updated Report 2024-05-17 210722
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Actual shortage 20MG Updated Report 2024-05-17 224645
COTAZYM ORGANON CANADA INC. Anticipated shortage 35000UNIT 40000UNIT 10000UNIT Updated Report 2024-05-17 225096
GABAPENTIN CAPSULES USP ACCORD HEALTHCARE INC Anticipated shortage 400MG New Report 2024-05-17 228242
VISIPAQUE 270 GE HEALTHCARE CANADA INC Actual shortage 550MG Updated Report 2024-05-17 227151
NUCYNTA EXTENDED-RELEASE ENDO OPERATIONS LTD. Actual shortage 200MG Updated Report 2024-05-17 205952

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ SENNA S SANDOZ CANADA INCORPORATED To be discontinued 50MG 8.6MG New Report 2024-05-17 228268
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED To be discontinued 40MG New Report 2024-05-17 228263
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED To be discontinued 20MG New Report 2024-05-17 228256
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED To be discontinued 10000UNIT New Report 2024-05-17 228249
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 9.45MG Updated Report 2024-05-17 228166